Перевести на Переведено сервисом «Яндекс.Перевод»

Sunesis Pharmaceuticals

Страна
USA
Краткое название
Sunesis Pharmaceuticals
Штаб квартира
395 Oyster Point Boulevard Suite 400
Члены правления

Daniel N. Swisher, Jr.,
Chief Executive Officer and President
Eric H. Bjerkholt,
Executive Vice President, Corporate Development and Finance, Chief Financial Officer
Adam R. Craig, M.D., Ph.D., M.B.A,
Executive Vice President, Development and Chief Medical Officer
Gene Jamieson,
Vice President of Chemistry, Manufacturing and Controls (CMC)
Deborah A. Thomas, Ph.D.,
Vice President, Regulatory Affairs and Medical Writing

Разделы медицины
Онкология
Стадия проекта
Производство
Заболевания
Рак крови, Рак кишечника, Рак желудка
Тикер
SNSS
Текущие владельцы

Matthew K. Fust,
Director
Ed Hurwitz,
Director
Steven B. Ketchum, Ph.D.,
Director
Helen Kim,
Director
Dayton Misfeldt,
Director
Homer L. Pearce, Ph.D.,
Director
David C. Stump, M.D.,
Director
Daniel N. Swisher, Jr.,
Chief Executive Officer and President
James W. Young, Ph.D.,
Chairman

Объем фонда
208.6700
Технологии
Клеточные технологии, Фармацевтика, Химия